Page 226 - GHES-3-3
P. 226
Global Health Economics and
Sustainability
COVID-19 vaccination decisions and mandate impact
Table 6. Accommodations, EDI considerations, and informed consent
Question Options n Percentage
Employer or regulatory authorities offered alternatives to Yes, testing on-site paid for by employer 1/166 8
vaccination Yes, test off-site at your cost 0/166 0
Yes, remote work 0/166 0
Yes, educational training 0/166 0
Yes, proof of natural immunity 0/166 0
No, they did not offer any alternatives to vaccination 155/166 93.4
Total respondents 156/166 94
No response 10/166 6
Requested exemption from vaccination N/A (e.g., my employer did not request mandatory vaccination, 3/166 2
and I did not need an exemption)
No, I was not interested in requesting an exemption 10/166 6
Yes, and I received an exemption 1/166 1
Yes, but I did not receive an exemption 73/166 44
No, I did not request an exemption (e.g., because I was 45/166 27.1
intimidated to ask for one)
Other 9/166 14.5
No response 10/166 6
Category of exemption N/A (did not apply for exemption) 74/166 44.6
Medical 38/166 23
Religious 41/166 25
Conscientious 16/166 10
Other 26/166 16
No response 12/166 7.2
Employer (or professional college or public health authority, Yes, I was provided a package insert from the vaccine 0/166 0
if self-employed) provided written information about the manufacturer (s)
vaccines Yes, I was provided information from public health agencies or 27/166 16.3
equivalent
No, they never provided me with written information about the 119/166 72
vaccines
Other 10/166 6
No response 11/166 7
If you received written information from your employer Yes 9/166 5.4
(or professional college or public health authority if No 33/166 20
self-employed), did it enable you to make an informed
decision about vaccination? I did not receive written information 99/166 60
Other 14/166 8.4
Total respondents 155/166 93.4
No response 11/166 7
Abbreviation: EDI: Equity, diversity, and inclusion; N/A: Not applicable.
and official sources (51/166, 31%), telling patients that the Significantly, close to one-fourth of the respondents
vaccines were safe and effective (44/166, 27%), dismissing (38/166, 23%) agreed (13/166, 8%) or strongly agreed
the information that did not align with official sources as (25/166, 15.1%) that they had felt coerced to recommend
“misinformation” (38/166, 23%), and denying exemptions or administer vaccines against their best clinical judgment.
(12/166, 7.2%) or off-label prescription (13/166, 8%) Most respondents (108/166, 65.1%) agreed (38/166,
requests (Table 8). 23%) or strongly agreed (70/166, 42.2%) that they had
Volume 3 Issue 3 (2025) 218 https://doi.org/10.36922/GHES025080014

